TIVOPATH (tivozanib hydrochloride), created in 2012 (United States), from 13 sister brands. TIVOPATH (tivozanib hydrochloride) is owned by Aveo Pharmaceuticals, listed on the stock exchange of New York The sector of TIVOPATH (tivozanib hydrochloride) is Divers.
Buy Aveo Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
